financetom
Business
financetom
/
Business
/
Canada's Exco Technologies Q3 sales misses estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Canada's Exco Technologies Q3 sales misses estimates
Jul 30, 2025 2:34 PM

Overview

* Exco ( EXCOF ) fiscal Q3 sales decline 4% yr/yr, missing analyst expectations, per LSEG data

* Net income for fiscal Q3 falls 34% yr/yr, reflecting challenging market conditions

* Company generated strong free cash flow, maintaining robust balance sheet

Outlook

* Exco ( EXCOF ) previously withdrew fiscal 2026 revenue, EBITDA, and EPS targets due to tariff uncertainty in Q2

* Company expects USMCA-compliant products to remain tariff-exempt long-term

* Exco ( EXCOF ) anticipates benefiting from North American reshoring trends

Result Drivers

* CUSTOMER DELAYS - Sales in the Automotive Solutions segment decreased due to customer-driven delays in program launches and unfavorable vehicle mix, as well as lower production volumes in North America and Europe

* WEAKENED DEMAND - Demand for die-cast tooling declined due to OEMs postponing new product development and launches amid soft consumer demand for EVs, political uncertainties, and tariff risks

* FOREIGN EXCHANGE IMPACT - Foreign exchange rate changes positively impacted sales by C$3.1 mln in the quarter

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Sales Miss C$154.90 C$155.70

mln mln (2

Analysts

)

Q3 EPS C$0.14

Q3 Net C$5.40

Income mln

Q3 Cash C$25.20

Flow mln

from

Operatin

g

Activiti

es

Q3 C$0.105

Dividend

Q3 C$14.70

EBITDA mln

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the auto, truck & motorcycle parts peer group is "buy"

* Wall Street's median 12-month price target for Exco Technologies Ltd ( EXCOF ) is C$7.75, about 10.6% above its July 29 closing price of C$6.93

* The stock recently traded at 7 times the next 12-month earnings vs. a P/E of 6 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Schlumberger Unit Gets Equinor Contract For All-Electric Subsea Project
Schlumberger Unit Gets Equinor Contract For All-Electric Subsea Project
Jun 27, 2024
10:36 AM EDT, 06/27/2024 (MT Newswires) -- Schlumberger ( SLB ) said Thursday its SLB OneSubsea unit has been awarded a contract by Equinor ( EQNR ) for the front-end engineering design of a 12-well, all-electric Subsea Production Systems project in the Fram Sor field, offshore Norway. As part of the agreement, future engineering, procurement and construction will be awarded...
Why Architectural Services Company Apogee Shares Are Trading Higher Today
Why Architectural Services Company Apogee Shares Are Trading Higher Today
Jun 27, 2024
Apogee Enterprises ( APOG ), Inc. reported first-quarter FY25 sales of $331.5 million, missing the consensus estimate of $333.2 million. Revenue fell 8.3% Y/Y, driven by lower volume. Gross margin improved by 410 basis points Y/Y to 29.8%, primarily driven by a more favorable mix of projects in Architectural Services, favorable material costs, lower insurance-related costs, and productivity gains. Adjusted operating income...
Update: American Lithium Up 4% As National Bank Notes Falchani Flow Sheet Update
Update: American Lithium Up 4% As National Bank Notes Falchani Flow Sheet Update "Shows Good Progress"
Jun 27, 2024
10:36 AM EDT, 06/27/2024 (MT Newswires) -- American Lithium ( AMLI ) said Thursday that it plans to commence piloting work for the Falchani lithium project in Peru during the second half of this year following strong results from the latest test work on the flowsheet. According to American Lithium ( AMLI ), Falchani's flowsheet utilizes warm sulfuric acid leaching...
X4 Pharmaceuticals Shares Fall After Trail Data Announced on Chronic Blood Disease Treatment
X4 Pharmaceuticals Shares Fall After Trail Data Announced on Chronic Blood Disease Treatment
Jun 27, 2024
10:44 AM EDT, 06/27/2024 (MT Newswires) -- X4 Pharmaceuticals ( XFOR ) shares fell 30% in recent Thursday trading even after the company said its phase 2 trial assessing the safety and efficacy of mavorixafor as a treatment for chronic neutropenia yielded positive interim clinical data. Interim analysis of the ongoing six-month study indicated once-daily oral mavorixafor was well tolerated...
Copyright 2023-2026 - www.financetom.com All Rights Reserved